Alternatives to Midi Health

One of the few candidates verified this pass spanning both a cheap compounded entry ($99/mo semaglutide) and a real brand-name Wegovy/Zepbound fallback, billed once per plan rather than monthly — text-only consult, no video visit, but no stated turnaround time.

No video visit and no membership fee — semaglutide from $117.96/mo, tirzepatide from $178.98/mo — but Trava's own pages currently disagree with each other on its clinical-partner name and its cheapest semaglutide price.

Coby publishes its whole dose-scaling ladder up front, which is rarer than it should be: read live on 2026-08-26, compounded semaglutide runs $159, $199, $229, then $249 and holds there, and tirzepatide runs $239, $299, $329, $379, then $439. Every rung is unchanged since early August. It also answers the two questions most sellers dodge. On video, its FAQ says outright that unless your state requires one, no video visit is needed and your provider reviews everything online. On coverage, it names the four states it does not reach — Arkansas, Louisiana, Mississippi and New Mexico — instead of staying vague. Two things go the other way. Coby's month is four weeks by its own arithmetic, since it sells a three-month bundle as twelve weeks and a six-month bundle as twenty-four, so a year is thirteen bills rather than twelve. And changing your mind costs money: canceling before the prescription reaches the pharmacy deducts a $50 non-refundable visit and clinical fee from the refund, and once it has been sent, the order cannot be changed at all.

LegitScript-certified and available in all 50 states at $149/mo ongoing (after a $124 first month) for compounded semaglutide — but it's a broad IV-therapy-and-hormone platform first, its own homepage banner prices the same program differently than its product page, and tirzepatide isn't offered as a compounded option. It also runs mobile IV therapy (Texas only), hormone replacement, and hair regrowth under the same brand, dispensing through 503A and 503B U.S.-licensed pharmacies per its own claim.

FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, and licensed in all 50 states. It also cites customer-reported outcomes (125k patients, 1M+ pounds lost) rather than leaving weight-loss claims unsourced.

It shows both prices at once and says which is which: $149/mo with no commitment, $79 on a twelve-month plan. Brand-name is listed, but all three pages say coming soon.

The number on the page is a prepay. Read live on 2026-08-26, GOAL.MD's semaglutide page leads with $99 a month and its tirzepatide page with $159 — and both are 12-month prepaid equivalents, $1,188 and $1,908 handed over up front. Month to month, the same two medications are $179 and $249. The site does say so, in the same sentence, but second. Everything around that pricing is unusually clean for this roster: a named physician with a searchable NPI rather than an anonymous clinical network, "No Auto-Billing. Ever." with a stated check-in before every renewal, a 3-minute online medical visit with no video call mentioned anywhere in the copy, and a published timeline — physician decision in about 24 hours, free shipping in 2–3 days. Two corrections to make if you are comparing: it serves 48 states rather than the whole country, and its brand-name lane is a forwarding service where you pay GOAL.MD $95 a month for supervision and the manufacturer program directly for the drug.

FDA warning letter #721479 (Feb. 2026), which names joinbliv.com. An explicitly no-video-visit, fully async intake — as low as $116/mo semaglutide, $199/mo tirzepatide — with CareCredit and Klarna pay-later options, though state coverage isn't published.

Trellis Vitality is the cheapest genuinely-disclosed option on this page: $150 a month for compounded semaglutide and $199 for tirzepatide, month to month, with every dosage available at the same price and no membership fee, no consult fee and a $0 assessment. Commit for three or six months and those fall to $140/$133 and $189/$179. It names the pharmacy that compounds the medication — Vials Rx, described as a US state-licensed, cGMP-compliant facility — which is the disclosure most of its cheaper competitors skip, and it covers all 50 states with board-certified clinicians reviewing intake. The caveats are about what it doesn't sell and doesn't say. There is no FDA-approved brand option, no oral formulation, and none of its pricing appears on the homepage at all — you have to reach the GLP-1 product page to find a single number, which makes it look more opaque than it actually is. There is also no postpartum, breastfeeding or PCOS content anywhere.